John R. Gatti

John R. Gatti

Auto-generated profile, based on publicly available information

John R. Gatti

Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2020 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
JGJohn R. Gatti
John R. Gatti
ATAdriana Gonzalez Torriente
Adriana Gonzalez Torriente
LSLisa R. Sun
Lisa R. Sun
Moyamoya arteriopathy, which can be idiopathic or associated with sickle cell disease, neurofibromatosis, Down syndrome, or cranial radiation therapy, is a progressive cerebral arteriopathy associated with high rates of incident and recurrent stroke. Little is known about how these subgroups differ with respect to clinical presentation, radiographic findings, stroke risk, and functional outcomes. Using ICD codes, we identified children ages 28 days to 18 years treated for moyamoya arteriopathy at our tertiary care center between 2003 and 2019. Demographic, clinical, and radiographic data were extracted from the medical record. The Pediatric Stroke Recurrence and Recovery Questionnaire was administered to consenting participants. Sixty-nine patients met inclusion criteria (33 idiopathic, 18 sickle cell disease, 11 neurofibromatosis, 6 Down syndrome, 1 cranial radiation therapy). Median follow-up time was 7.7 years; 24 patients had at least 5 years of follow-up data. Frequency of stroke at presentation differed by subgroup (P < .001). Of patients with at least 2 years of follow-up, 33 (55%) experienced stroke. The proportion of patients experiencing stroke differed by subgroup (50% of idiopathic cases, 72% of sickle cell disease, 11% of neurofibromatosis, and 100% of Down syndrome, P = .003). The frequency of bilateral versus unilateral disease (P = .001) and stroke-free survival following presentation (P = .01) also differed by subgroup. In this single-center cohort, moyamoya subgroups differed with respect to clinical and radiographic characteristics, with neurofibromatosis-associated moyamoya syndrome having a milder phenotype and Down syndrome–associated moyamoya portending a more aggressive course. These findings need confirmation in a larger, multi-center cohort with longer duration of follow-up.

1 July 2021 in Pediatric Neurology
Verified
Journal Article
Closed access
ADAnia K. Dabrowski
Ania K. Dabrowski
MCMelisa Carrasco
Melisa Carrasco
JGJohn R. Gatti
John R. Gatti
ABAndre R.F. Barreto
Andre R.F. Barreto
CPCharlamaine Parkinson
Charlamaine Parkinson
LSLisa R. Sun
Lisa R. Sun

7 April 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
KYKelly Z. Young
Kelly Z. Young
CRCarolina Rojas Ramírez
Carolina Rojas Ramírez
SKSimon G. Keep
Simon G. Keep
JGJohn R. Gatti
John R. Gatti
SLSoo Jung Lee
Soo Jung Lee
MWMichael M. Wang
Michael M. Wang
Cerebral small vessel disease (SVD) is a prevalent disease of aging and a major contributor to stroke and dementia. The most commonly inherited SVD, CADASIL, is caused by dominantly acting cysteine-altering mutations in NOTCH3. These mutations change the number of cysteines from an even to an odd number, but the impact of these alterations on NOTCH3 protein structure remain unclear. Here, we prepared wildtype and four mutant recombinant NOTCH3 protein fragments to analyze the impact of CADASIL mutations on oligomerization, thiol status, and protein stability. Using gel electrophoresis, tandem MS/MS, and collision-induced unfolding, we find that NOTCH3 mutant proteins feature increased amounts of inappropriate disulfide bridges, reduced cysteines, and structural instability. Presence of a second protein factor, an N-terminal fragment of NOTCH3 (NTF), is capable of further altering disulfide statuses of both wildtype and mutant proteins, leading to increased numbers of reduced cysteines and further destabilization of NOTCH3 structure. In sum, these studies identify specific cysteine residues alterations and quaternary structure induced by CADASIL mutations in NOTCH3; further, we validate that reductive factors alter the structure and stability of this small vessel disease protein.

21 September 2022 in Journal of Child Neurology
Verified
Journal Article
Closed access
SYSarah E. Gardner Yelton
Sarah E. Gardner Yelton
JGJohn Gatti
John Gatti
MAMalik Adil
Malik Adil
MGMelike Guryildirim
Melike Guryildirim
ATAylin Tekes
Aylin Tekes
LSLisa R. Sun
Lisa R. Sun
Patients with moyamoya arteriopathy are at high risk for developing ischemic stroke in the perioperative period. We sought to evaluate whether preoperative clinical and neuroimaging biomarkers are associated with postoperative stroke and transient ischemic attack in children with moyamoya following revascularization surgery. We performed a retrospective chart review of pediatric patients who underwent revascularization surgery for moyamoya in the last 15 years. Fifty-three patients who underwent 69 surgeries met the inclusion criteria. We recorded clinical predictors of stroke or transient ischemic attack within 7 days following surgery. We used Suzuki stage and Composite Cerebrovascular Stenosis Score to analyze neuroimaging. Significant risk factors for developing postoperative stroke or transient ischemic attack were younger age at surgery ( P = .004) and transient ischemic attack less than 1 month prior to surgery ( P < .001). Children under 5 and those with recent preoperative ischemic events should be the focus of investigation to evaluate modifiable risk factors and targeted interventions.

30 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SLSoo Jung Lee
Soo Jung Lee
SKSoonhyung Kwon
Soonhyung Kwon
JGJohn R. Gatti
John R. Gatti
EKEjona Korcari
Ejona Korcari
TGTy E. Gresser
Ty E. Gresser
MWMichael M. Wang
Michael M. Wang
The human cerebrovascular system is responsible for regulating demand-dependent perfusion and maintaining the blood-brain barrier (BBB). In addition, defects in the human cerebrovasculature lead to stroke, intracerebral hemorrhage, vascular malformations, and vascular cognitive impairment. The objective of this study was to discover new proteins of the human cerebrovascular system using expression data from the Human Protein Atlas, a large-scale project which allows public access to immunohistochemical analysis of human tissues. We screened 20,158 proteins in the HPA and identified 346 expression patterns correlating to blood vessels in human brain. Independent experiments showed that 51/52 of these distributions could be experimentally replicated across different brain samples. Some proteins (40%) demonstrated endothelial cell (EC)-enriched expression, while others were expressed primarily in vascular smooth muscle cells (VSMC; 18%); 39% of these proteins were expressed in both cell types. Most brain EC markers were tissue oligospecific; that is, they were expressed in endothelia in an average of 4.8 out of 9 organs examined. Although most markers expressed in endothelial cells of the brain were present in all cerebral capillaries, a significant number (21%) were expressed only in a fraction of brain capillaries within each brain sample. Among proteins found in cerebral VSMC, virtually all were also expressed in peripheral VSMC and in non-vascular smooth muscle cells (SMC). Only one was potentially brain specific: VHL (Von Hippel-Lindau tumor suppressor). HRC (histidine rich calcium binding protein) and VHL were restricted to VSMC and not found in non-vascular tissues such as uterus or gut. In conclusion, we define a set of brain vascular proteins that could be relevant to understanding the unique physiology and pathophysiology of the human cerebrovasculature. This set of proteins defines inter-organ molecular differences in the vasculature and confirms the broad heterogeneity of vascular cells within the brain.

22 June 2018 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
JGJohn R. Gatti
John R. Gatti
XZXiaojie Zhang
Xiaojie Zhang
EKEjona Korcari
Ejona Korcari
SLSoo Jung Lee
Soo Jung Lee
NGNya Greenstone
Nya Greenstone
MWMichael M. Wang
Michael M. Wang